Costs of bronchoalveolar lavage-directed therapy in the first 5 years of life for children with cystic fibrosis.
Moodie,M, Lal,A, Vidmar,S, Armstrong,DS, Byrnes,CA, Carlin,JB, Cheney,J, Cooper,PJ, Grimwood,K, Robertson,CF, Tiddens,HA and Wainwright,CE 2014, Costs of bronchoalveolar lavage-directed therapy in the first 5 years of life for children with cystic fibrosis., The Journal of Pediatrics, vol. 165, no. 3, pp. 564-569.e5, doi: 10.1016/j.jpeds.2014.05.031.
Attached Files
Name
Description
MIMEType
Size
Downloads
Title
Costs of bronchoalveolar lavage-directed therapy in the first 5 years of life for children with cystic fibrosis.
To determine whether bronchoalveolar lavage (BAL)-directed therapy for infants and young children with cystic fibrosis (CF), rather than standard therapy, was justified on the grounds of a decrease in average costs and whether the use of BAL reduced treatment costs associated with hospital admissions.
Notes
Also contributed by The Australasian Cystic Fibrosis Bronchoalveolar Lavage Study Investigators
Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.